Matches in Wikidata for { <http://www.wikidata.org/entity/Q97526804> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q97526804 description "article scientifique publié en 2020" @default.
- Q97526804 description "artículu científicu espublizáu en xunu de 2020" @default.
- Q97526804 description "scientific article published on 04 June 2020" @default.
- Q97526804 description "wetenschappelijk artikel" @default.
- Q97526804 description "наукова стаття, опублікована 4 червня 2020" @default.
- Q97526804 name "Intracranial Response of ALK+ Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery" @default.
- Q97526804 name "Intracranial Response of ALK+ Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery" @default.
- Q97526804 type Item @default.
- Q97526804 label "Intracranial Response of ALK+ Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery" @default.
- Q97526804 label "Intracranial Response of ALK+ Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery" @default.
- Q97526804 prefLabel "Intracranial Response of ALK+ Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery" @default.
- Q97526804 prefLabel "Intracranial Response of ALK+ Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery" @default.
- Q97526804 P1433 Q97526804-0A4DFE05-61A6-4529-A975-CC3558F94A0A @default.
- Q97526804 P1476 Q97526804-ABE9C2BD-AE48-4D68-8419-F663DD89AF61 @default.
- Q97526804 P2093 Q97526804-02EB4E9F-E240-459B-981F-0FDAAB4E09F6 @default.
- Q97526804 P2093 Q97526804-142063B2-F962-4292-B829-94002C793061 @default.
- Q97526804 P2093 Q97526804-16A66854-E587-4EF3-9373-100B786296CB @default.
- Q97526804 P2093 Q97526804-4FE8ED69-53E0-4D3C-A6D0-5B0B7B59976D @default.
- Q97526804 P2093 Q97526804-6B08F3BA-8E0D-4079-B130-65EC2933FD31 @default.
- Q97526804 P2860 Q97526804-8F149182-FD63-4A1E-B641-8E50007BA900 @default.
- Q97526804 P31 Q97526804-70F21075-E510-44D3-8C73-31073EEE8C20 @default.
- Q97526804 P356 Q97526804-85033136-5E10-4A5D-A9A7-98A6F581925F @default.
- Q97526804 P577 Q97526804-AB775CC8-FA9C-4E19-96F6-82FDC91C12F2 @default.
- Q97526804 P698 Q97526804-C7467375-683C-4E98-A954-8B35E79C9FF2 @default.
- Q97526804 P921 Q97526804-FA14EBDA-B229-4D9E-8B90-547D53DD3FC5 @default.
- Q97526804 P356 J.CLLC.2020.04.012 @default.
- Q97526804 P698 32651064 @default.
- Q97526804 P1433 Q332299 @default.
- Q97526804 P1476 "Intracranial Response of ALK+ Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery" @default.
- Q97526804 P2093 "Edyta Maria Urbanska" @default.
- Q97526804 P2093 "Eric Santoni-Rugiu" @default.
- Q97526804 P2093 "Jens Benn Sørensen" @default.
- Q97526804 P2093 "Jonathan Frederik Carlsen" @default.
- Q97526804 P2093 "Linea Cecilie Melchior" @default.
- Q97526804 P2860 Q29615679 @default.
- Q97526804 P31 Q13442814 @default.
- Q97526804 P356 "10.1016/J.CLLC.2020.04.012" @default.
- Q97526804 P577 "2020-06-04T00:00:00Z" @default.
- Q97526804 P698 "32651064" @default.
- Q97526804 P921 Q10294943 @default.